IL156690A0 - Specific human antibodies for selective cancer therapy - Google Patents

Specific human antibodies for selective cancer therapy

Info

Publication number
IL156690A0
IL156690A0 IL15669001A IL15669001A IL156690A0 IL 156690 A0 IL156690 A0 IL 156690A0 IL 15669001 A IL15669001 A IL 15669001A IL 15669001 A IL15669001 A IL 15669001A IL 156690 A0 IL156690 A0 IL 156690A0
Authority
IL
Israel
Prior art keywords
human antibodies
cancer therapy
specific human
selective cancer
selective
Prior art date
Application number
IL15669001A
Other languages
English (en)
Original Assignee
Savient Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Savient Pharmaceuticals Inc filed Critical Savient Pharmaceuticals Inc
Publication of IL156690A0 publication Critical patent/IL156690A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL15669001A 2000-12-29 2001-12-31 Specific human antibodies for selective cancer therapy IL156690A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75118100A 2000-12-29 2000-12-29
PCT/US2001/049440 WO2002059264A2 (fr) 2000-12-29 2001-12-31 Anticorps humains specifiques pour la therapie selective du cancer

Publications (1)

Publication Number Publication Date
IL156690A0 true IL156690A0 (en) 2004-01-04

Family

ID=25020844

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15669001A IL156690A0 (en) 2000-12-29 2001-12-31 Specific human antibodies for selective cancer therapy

Country Status (15)

Country Link
EP (1) EP1353937A4 (fr)
JP (1) JP2004524023A (fr)
KR (1) KR20030091952A (fr)
CN (1) CN100374456C (fr)
AU (1) AU2002246737B2 (fr)
BR (1) BR0116763A (fr)
CA (1) CA2433227A1 (fr)
CZ (1) CZ20031983A3 (fr)
HU (1) HUP0400775A2 (fr)
IL (1) IL156690A0 (fr)
MX (1) MXPA03005944A (fr)
NZ (1) NZ527173A (fr)
PL (1) PL365758A1 (fr)
RU (1) RU2316564C2 (fr)
WO (1) WO2002059264A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2491427A1 (fr) * 2002-07-01 2004-01-08 Savient Pharmaceuticals, Inc. Compositions et procedes pour traitement therapeutique
CN1897970A (zh) * 2003-06-30 2007-01-17 生物技术通用（以色列）有限公司 特异人抗体
GEP20115226B (en) 2005-04-26 2011-06-10 Pfizer P-cadherin antibodies
CA2747154C (fr) 2008-12-19 2015-11-10 Philogen S.P.A. Immunocytokines pour therapie tumorale avec agents chimiotherapiques
NZ604805A (en) * 2010-07-09 2014-09-26 Affibody Ab Polypeptides
CN101948534B (zh) * 2010-08-19 2014-05-28 中国科学院生物物理研究所 一种筛选抗体的方法
GB201310544D0 (en) * 2013-06-13 2013-07-31 Ucb Pharma Sa Obtaining an improved therapeutic ligand
CA2962275C (fr) * 2014-10-23 2019-11-05 Singh Biotechnology, Llc Anticorps a domaine unique diriges contre des antigenes intracellulaires
SG11201704726VA (en) * 2014-12-17 2017-07-28 Intrexon Corp Intercalated single-chain variable fragments
GB201506868D0 (en) * 2015-04-22 2015-06-03 Ucb Biopharma Sprl Method for protein purification
WO2017055635A1 (fr) * 2015-10-01 2017-04-06 Ospedale San Raffaele S.R.L. Tcr et utilisations associées
ES2873846T3 (es) * 2015-11-19 2021-11-04 Revitope Ltd Complementación de fragmento de anticuerpo funcional para un sistema de dos componentes para eliminación redirigida de células no deseadas
JP7030109B2 (ja) * 2016-09-14 2022-03-04 テネオバイオ， インコーポレイテッド Ｃｄ３結合抗体
KR20230140553A (ko) * 2020-11-13 2023-10-06 프로메테우스 바이오사이언시즈, 인크. Tl1a를 표적으로 하는 염증성 질환의 치료를 위한 방법, 시스템, 및 키트

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140470A (en) * 1995-06-30 2000-10-31 Yale University Human monoclonal anti-tumor antibodies
BR9806793A (pt) * 1997-01-22 2000-05-16 Univ Texas Processos e composições de fator tissular para coagulação e tratamento de tumores.

Also Published As

Publication number Publication date
WO2002059264A2 (fr) 2002-08-01
AU2002246737B2 (en) 2007-03-01
CN100374456C (zh) 2008-03-12
RU2316564C2 (ru) 2008-02-10
EP1353937A2 (fr) 2003-10-22
EP1353937A4 (fr) 2005-04-13
KR20030091952A (ko) 2003-12-03
NZ527173A (en) 2006-03-31
HUP0400775A2 (en) 2007-05-02
CN1551886A (zh) 2004-12-01
JP2004524023A (ja) 2004-08-12
WO2002059264A3 (fr) 2003-03-06
CA2433227A1 (fr) 2002-08-01
RU2003123100A (ru) 2005-03-10
CZ20031983A3 (cs) 2005-07-13
PL365758A1 (en) 2005-01-10
BR0116763A (pt) 2004-03-09
MXPA03005944A (es) 2005-04-29

Similar Documents

Publication Publication Date Title
EP1311262A4 (fr) Traitement combine contre le cancer
GB2386120B (en) Differentiated cells suitable for human therapy
EP1572131A4 (fr) Therapie fondee sur les anticorps
GB0028429D0 (en) Therapy
EP1296697A4 (fr) Agents therapeutiques - i
IL214262A0 (en) Therapeutic human anti-il-1r1 monoclonal antibody
AU2001251348A1 (en) Apparatus for sensing human prostate tumor
HUP0400775A2 (en) Specific human antibodies for selective cancer therapy
HUP0300005A3 (en) Modified cytokines for use in cancer therapy
GB2367993B (en) Radiotherapy apparatus
EP1178829A4 (fr) Anticorps monoclonal humain
AU2002351374A8 (en) Antibodies to treat cancer
GB0001710D0 (en) Therapeutic treatment
GB0005257D0 (en) Breast cancer hormonal therapy
EP1401494A4 (fr) Traitement anti-tumoral
AU144325S (en) Therapy device
AU2096002A (en) Therapeutic treatment
GB0026015D0 (en) Cancer treatment
GB2374018B (en) Ultrasound therapy
GB0022216D0 (en) Human FAP-a-specific antibodies for use in cancer therapy
EP1463511A4 (fr) Therapie anticancereuse combinatoire
SI1157041T1 (sl) Protitelesa za terapijo in diagnozo raka
GB0024673D0 (en) Therapeutic antibodies
GB9914057D0 (en) Antibody therapy
GB9927698D0 (en) Therapeutic antibody